Clonal Hematopoiesis in Vexas Syndrome
Bhavisha A. Patel(MACOM (United States)), Neal S. Young(National Heart Lung and Blood Institute), Matthew J. Koster(Mayo Clinic in Arizona), Sofia Rosenzweig(Rady Children's Hospital-San Diego), Hugh Alessi(National Institutes of Health), Horatiu Olteanu(Mayo Clinic in Arizona), Ronald S. Go(Mayo Clinic), Daniel L. Kastner(National Institutes of Health), Jenna A. Fernandez(Mayo Clinic in Florida), Katherine R. Calvo(National Institutes of Health Clinical Center), Kenneth J. Warrington(Mayo Clinic), Zhuoer Xie(Mayo Clinic), Lorena Wilson(National Institutes of Health), Emma M. Groarke(MACOM (United States)), David B. Beck(Center for Human Genetics), Ruba Shalhoub(National Heart Lung and Blood Institute), Dalton Hironaka(National Heart Lung and Blood Institute), Amanda K. Ombrello(National Human Genome Research Institute), Yael Kusne(WinnMed), Mrinal M. Patnaik(Mayo Clinic), Taxiarchis Kourelis(Mayo Clinic in Arizona), Christy M. Finke(Mayo Clinic), Colin O. Wu(National Heart Lung and Blood Institute), Kebede H. Begna(Mayo Clinic), Ivana Darden(National Heart Lung and Blood Institute), Xiaoyang Ma(Kyung Hee University), Kaaren K. Reichard(Mayo Clinic), Marcela A. Ferrada(University of Maryland, Baltimore), Fernanda Gutierrez‐Rodrigues(National Heart Lung and Blood Institute), Peter C. Grayson(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Terra L. Lasho(Mayo Clinic), David S. Viswanatha(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic)
Cited by 6
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k